While smoking behavior is sustained biologically by candidate nicotine genes, such as the normal nicotine metabolizer CYP2A6 as well as other candidate nicotine genes, including dopamine receptors and CYP2B6 gene variants [24, 25], information about these genes is not used in current nicotine dependence treatment. Here, CYP2B6 is linked to nicotine dependence.